Sinking ship - Researcher insitro Employee Review

2.0
25 Aug 2023
Recommend
CEO approval
Business outlook

Pros

Free lunch is there, coffee barista and insurance. Benefits is good.

Cons

5 and a half years company as of today. Took 750 million from investors. 250 people employees. No pipeline, platform, compounds, or product to be seen..... Titanic.

Explore other reviews about insitro

5.0
11 Sept 2024
Recommend
CEO approval
Business outlook

Pros

Amazing CEO and fascinating work. Appreciated the great team I was on and the wonderful colleagues.

Cons

None come to mind right now!

2.0
4 Aug 2025
Recommend
CEO approval
Business outlook

Pros

Great cafeteria, benefits, low workload.

Cons

Management is clueless about how drugs discovery works, forget applying AI to it. Most scientists have no idea what to do beyond surviving the quarter and their current manager. Proof? 7 years after founding, they barely have a pipeline, nothing in the clinic and "one" target discovered for ALS. One target after raising 800 million. Nepotism is rampant. You will see 30 y/o "associate directors" with no direct reports or management experience. AI/ML and biology work in complete silos. Good place if you want to just coast and take a pay-cheque. Bad place if you are serious about your career.

9
See reviews by: Helpful|Rating|Date|All